Remedy Meds Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 8

Remedy Meds General Information

Description

Developer of a telehealth platform designed to facilitate access to medical weight-loss treatment. The company's platform offers online consultations, prescription medications, clinician support, and home delivery services, enabling individuals to access personalized, continuous weight-management programs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 480 Morris Avenue
  • Summit, NJ 07901
  • United States
+1 (551)
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Consumer Non-Durables
Clinics/Outpatient Services
Corporate Office
  • 480 Morris Avenue
  • Summit, NJ 07901
  • United States
+1 (551)

Remedy Meds Timeline

20252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Remedy Meds Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Jan-2026 Completed Generating Revenue
1. Seed Round 17-Nov-2025 Completed Generating Revenue
To view Remedy Meds’s complete valuation and funding history, request access »

Remedy Meds Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed
Series A 500,493 $0.000010 $99.9 $99.9 1x $99.9 0%
To view Remedy Meds’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Remedy Meds Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
137 Ventures Venture Capital Minority
Alpha Partners Venture Capital Minority
Wittington Ventures Venture Capital Minority
Dynamism Capital Venture Capital Minority
Gurtin Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Remedy Meds Acquisitions (1)

Remedy Meds’s most recent deal was a Merger/Acquisition with Thirty Madison for . The deal was made on 12-Aug-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Thirty Madison 12-Aug-2025 Merger/Acquisition Clinics/Outpatient Services
To view Remedy Meds’s complete acquisitions history, request access »

Remedy Meds FAQs

  • When was Remedy Meds founded?

    Remedy Meds was founded in 2024.

  • Where is Remedy Meds headquartered?

    Remedy Meds is headquartered in Summit, NJ.

  • What industry is Remedy Meds in?

    Remedy Meds’s primary industry is Enterprise Systems (Healthcare).

  • Is Remedy Meds a private or public company?

    Remedy Meds is a Private company.

  • What is Remedy Meds’s current revenue?

    The current revenue for Remedy Meds is .

  • How much funding has Remedy Meds raised over time?

    Remedy Meds has raised $2.9M.

  • Who are Remedy Meds’s investors?

    137 Ventures, Alpha Partners, Wittington Ventures, Dynamism Capital, and Gurtin Ventures are 5 of 8 investors who have invested in Remedy Meds.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process